Potential Tobacco-Based Vaccine Could Rival Egg-Based Vaccines
A new tobacco-based seasonal influenza vaccine being developed by Mitsubishi Tanabe Pharma and currently in Phase III studies could potentially rival traditional chicken egg-based vaccines.
Scientists Find a Potential Cure for Cancer
Scientists from Harvard, MIT and University College London have made a discovery about the genetics of cancer tumors that could offer a new way to deliver customized immunotherapy drugs to kill all types of cancer, including the most complex such as melanoma and lung cancer.
Meta-Analysis Reveals No Evidence that IVIG Administration Increases Risk of Thromboembolic Events
Analysis of 31 randomized controlled trials (RCTs) published between 1995 and 2015 found no evidence of increased thromboembolic event (TEE) risk among patients treated with intravenous immune globulin (IVIG) compared to control patients, according to a report by a team of investigators that included epidemiologists at the U.S. Food and Drug
Administration.
Second Biosimilar Drug in U.S. Is Approved by FDA
The U.S. Food and Drug Administration has approved Celltrion’s Inflectra (infliximab-dyyb), a biosimilar version of Johnson & Johnson’s Remicade drug used to treat autoimmune diseases.
FDA Expands Approval of Combination Therapy for Melanoma
The U.S. Food and Drug Administration has approved Opdivo (nivolumab) in combination with Yervoy (ipilimumab) for the treatment of patients with BRAFV600 wildtype and BRAFV600 mutation-positive unresectable or metastatic melanoma.
Malaria Vaccine Candidate Generates Robust Immune Response
Findings from a first in-human study for a new malaria vaccine candidate have shown a robust immune response while significantly delaying parasitemia.
New Gene Therapy Could Be Safe, Effective for Hemophilia B Patients
A new kind of gene therapy tested in animals could be safe and effective for human patients with hemophilia B.
2015-16 Flu Vaccine Is Nearly 60 Percent Effective
Preliminary overall 2015-16 influenza vaccine effectiveness was 59 percent, according to the Centers for Disease Control and Prevention.
FDA Approves Keytruda to Treat Lung Cancer
The U.S. Food and Drug Administration granted accelerated approval for pembrolizumab (Keytruda, Merck & Co.) for treatment of patients with advanced (metastatic)
non-small cell lung cancer.
Newly Approved Drug Reverses Effects of Neuromuscular Blocking Drugs Used During Surgery
The U.S. Food and DrugAdministration approved Merck and Co.’s Bridion (sugammadex) injection to reverse the effects of neuromuscular blockade induced by rocuroniumbromide and vecuronium bromide.
